442 related articles for article (PubMed ID: 33209440)
1. Combinational immunotherapy based on immune checkpoints inhibitors in small cell lung cancer: is this the beginning to reverse the refractory situation?
Guo H; He Y; Chen P; Wang L; Li W; Chen B; Liu Y; Wang H; Zhao S; Zhou C
J Thorac Dis; 2020 Oct; 12(10):6070-6089. PubMed ID: 33209440
[TBL] [Abstract][Full Text] [Related]
2. PD-1/PD-L1 Blockade Therapy in Advanced Non-Small-Cell Lung Cancer: Current Status and Future Directions.
Xia L; Liu Y; Wang Y
Oncologist; 2019 Feb; 24(Suppl 1):S31-S41. PubMed ID: 30819829
[TBL] [Abstract][Full Text] [Related]
3. Immune Checkpoint Inhibitors (ICIs) in Non-Small Cell Lung Cancer (NSCLC).
Yoneda K; Imanishi N; Ichiki Y; Tanaka F
J UOEH; 2018; 40(2):173-189. PubMed ID: 29925736
[TBL] [Abstract][Full Text] [Related]
4. First-Line Immune-Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Current Landscape and Future Progress.
Huang Z; Su W; Lu T; Wang Y; Dong Y; Qin Y; Liu D; Sun L; Jiao W
Front Pharmacol; 2020; 11():578091. PubMed ID: 33117170
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy as a treatment for small cell lung cancer: a case report and brief review.
Wu Y; Liu Y; Sun C; Wang H; Zhao S; Li W; Chen B; Wang L; Ye L; He Y; Zhou C
Transl Lung Cancer Res; 2020 Apr; 9(2):393-400. PubMed ID: 32420081
[TBL] [Abstract][Full Text] [Related]
6. Comparative efficacy and safety of first-line treatments for advanced non-small cell lung cancer with immune checkpoint inhibitors: A systematic review and meta-analysis.
Chen R; Hou X; Yang L; Zhao D
Thorac Cancer; 2019 Apr; 10(4):607-623. PubMed ID: 30734504
[TBL] [Abstract][Full Text] [Related]
7. Immune checkpoint inhibitors in small cell lung cancer.
Pakkala S; Owonikoko TK
J Thorac Dis; 2018 Feb; 10(Suppl 3):S460-S467. PubMed ID: 29593891
[TBL] [Abstract][Full Text] [Related]
8. Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer.
Herzberg B; Campo MJ; Gainor JF
Oncologist; 2017 Jan; 22(1):81-88. PubMed ID: 27534574
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy for small cell lung cancer: established applications and novel approaches.
Scott SC; Hann CL
Clin Adv Hematol Oncol; 2021 Oct; 19(10):654-663. PubMed ID: 34637432
[TBL] [Abstract][Full Text] [Related]
10. Current status and future perspectives of immune checkpoint inhibitors in extensive-stage small cell lung cancer.
Liu X; Xing H; Liu B
Am J Cancer Res; 2022; 12(6):2447-2464. PubMed ID: 35812062
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs as regulators of immune checkpoints in cancer immunotherapy: targeting PD-1/PD-L1 and CTLA-4 pathways.
Zabeti Touchaei A; Vahidi S
Cancer Cell Int; 2024 Mar; 24(1):102. PubMed ID: 38462628
[TBL] [Abstract][Full Text] [Related]
12. [Immunotherapy Advances in Small Cell Lung Cancer].
Xu Y; Zhan P; Song Y
Zhongguo Fei Ai Za Zhi; 2020 Nov; 23(11):989-998. PubMed ID: 32752583
[TBL] [Abstract][Full Text] [Related]
13. [Clinical Research Progress of Immune Checkpoint Inhibitors in the Treatment of
Small Cell Lung Cancer].
Huang B; Duan Y
Zhongguo Fei Ai Za Zhi; 2019 Apr; 22(4):239-244. PubMed ID: 31014443
[TBL] [Abstract][Full Text] [Related]
14. Advances in immune checkpoint inhibitors therapy for small cell lung cancer.
Li L; Liang Y; Yu M; Zhao L; Mei Q; Yu Y; Wang N; Zhang D; Wang Z; Jia Y; Kong F
Cancer Med; 2023 May; 12(10):11097-11106. PubMed ID: 36880420
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers for Immune Checkpoint Inhibitor-Mediated Tumor Response and Adverse Events.
Nakamura Y
Front Med (Lausanne); 2019; 6():119. PubMed ID: 31192215
[TBL] [Abstract][Full Text] [Related]
16. Combination therapy: Future directions of immunotherapy in small cell lung cancer.
Huang W; Chen JJ; Xing R; Zeng YC
Transl Oncol; 2021 Jan; 14(1):100889. PubMed ID: 33065386
[TBL] [Abstract][Full Text] [Related]
17. Immune checkpoint inhibitors in lung cancer: current status and future directions.
Fan Y; Mao W
Chin Clin Oncol; 2017 Apr; 6(2):17. PubMed ID: 28482670
[TBL] [Abstract][Full Text] [Related]
18. Immune checkpoint inhibitors in elderly patients treated for a lung cancer: a narrative review.
Naltet C; Besse B
Transl Lung Cancer Res; 2021 Jun; 10(6):3014-3028. PubMed ID: 34295694
[TBL] [Abstract][Full Text] [Related]
19. Immune checkpoint inhibitors for small cell lung cancer: opportunities and challenges.
Regzedmaa O; Zhang H; Liu H; Chen J
Onco Targets Ther; 2019; 12():4605-4620. PubMed ID: 31354294
[TBL] [Abstract][Full Text] [Related]
20. Use of targeted next generation sequencing to characterize tumor mutational burden and efficacy of immune checkpoint inhibition in small cell lung cancer.
Ricciuti B; Kravets S; Dahlberg SE; Umeton R; Albayrak A; Subegdjo SJ; Johnson BE; Nishino M; Sholl LM; Awad MM
J Immunother Cancer; 2019 Mar; 7(1):87. PubMed ID: 30922388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
